KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Capital Expenditures (2018 - 2025)

Progyny (PGNY) has disclosed Capital Expenditures for 8 consecutive years, with -$2.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures changed N/A to -$2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a N/A change, with the full-year FY2025 number at $681000.0, up 173.49% from a year prior.
  • Capital Expenditures was -$2.8 million for Q4 2025 at Progyny, down from $1.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.5 million in Q3 2023 to a low of -$2.8 million in Q4 2025.
  • A 5-year average of $490352.9 and a median of $490000.0 in 2022 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 3850.0% in 2022; the steepest drop was 834.15% in 2022.
  • Progyny's Capital Expenditures stood at $1.9 million in 2021, then plummeted by 70.01% to $560000.0 in 2022, then increased by 21.61% to $681000.0 in 2023, then skyrocketed by 163.44% to $1.8 million in 2024, then plummeted by 257.69% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Capital Expenditures are -$2.8 million (Q4 2025), $1.2 million (Q1 2025), and $1.8 million (Q3 2024).